Renal carbonic anhydrase inhibition by benzolamide (CL 11,366) in man.
D000042:Absorption; D000138:Acidosis; D001639:Bicarbonates / Q000097:blood / Q000652:urine; D001773:Blood Cells / Q000187:drug effects; D001774:Blood Chemical Analysis; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000652:urine; D004573:Electrolytes / Q000097:blood / Q000652:urine; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D005082:Physical Exertion; D011188:Potassium / Q000652:urine; D012119:Respiration / Q000187:drug effects; D012964:Sodium / Q000652:urine; D013451:Sulfonic Acids / Q000494:pharmacology*; D013844:Thiazoles / Q000494:pharmacology*
D001639:Bicarbonates; D002257:Carbonic Anhydrase Inhibitors; D004573:Electrolytes; D013451:Sulfonic Acids; D013844:Thiazoles; D012964:Sodium; D011188:Potassium